US Organ Transplant Pharmaceuticals Markets

Document Sample
US Organ Transplant Pharmaceuticals Markets Powered By Docstoc
More information from

U.S. Organ Transplant Pharmaceuticals Markets

Description:    Organ Transplantation Pharmaceuticals: New Therapies, New Solutions
                Impressive developments in the field of transplant immunosuppression therapies have given rise to
                high expectations of revolutionary solutions in the near future. New side-effect sparing chronic
                immunosuppressive drugs and prophylactic uses of acute immunosuppressive therapies such as
                monoclonal and polyclonal antibodies are making transplantation one of the most successful and
                promising areas of medicine.

                This Frost & Sullivan research on the U.S. Organ Transplant Pharmaceuticals Markets spans the
                most important aspects of the solid organ transplant market - research and development (R&D)
                products, top competitors, demand and revenue forecasts from 1998 to 2008, challenges and
                opportunities, and technology trends. This study covers chronic and acute immunosuppressants

                Improved Survival Rates and New Patient Groups Provide Market Opportunity

                Since the advent of organ transplants, survival rates of transplant recipients have improved, and, it
                is expected that there will be a sustained demand for improved anti-rejection pharmaceuticals.
                Also, a rise in organ transplants that were previously rare, such as those of the intestines, lung,
                and kidney-pancreas, intensify the demand for improved immunosuppressants. Adverse side-effect
                profiles weigh down on many of the current therapeutics providing pharmaceutical companies
                tremendous initiative to develop drugs that are safer and more effective.

                Prospective markets lie in new patient groups such as children, pregnant women, and ethnic
                groups, whose immune system may require different doses/types of immunosuppression. As well,
                currently marketed products may opt to seek FDA approval for use in additional types of
                transplants. "The opportunity for expanded indications across the organ transplant field creates
                profit potentials for anti-rejection pharmaceuticals," says the analyst.

                Prophylactic Use of Immunosuppressants Contributes to Revenues

                According to the author, "In acute immunosuppression markets, there is a trend towards increasing
                prophylactic use of monoclonal and polyclonal antibodies." Superior efficacy and long-term
                improvements in organ transplant outcomes are factors that are more important than price in this
                market. Therefore, this market is quality-driven rather than price-driven.

                With several ongoing research and development projects for both chronic and acute
                immunosuppressants, the market can expect the introduction of innovative products that will offer
                clinical solutions to some of the currently unmet market needs.

Contents:       1 Executive Summary
                 A. Executive Summary
                 1 Executive Summary

                 2 Total Market
                 A. Overview
                 1 The Immune System and Organ Transplant Rejection
                 2 The History of Organ Transplant Immunosuppression
                 3 The Nature of the Market
                 4 Report Scope and Segmentation
                 B. Market Dynamics
                 1 Challenges
                 2 Drivers
                 3 Restraints
 4 Market Engineering Analysis
 C. Forecasts and Trends
 1 Market and Technology Trends
 2 Revenue Forecasts
 3 Market Share Analysis
 D. Strategic Recommendations
 1 Strategic Recommendation 1
 2 Strategic Recommendation 2
 3 Strategic Recommendation 3
 E. Market Engineering Awards
 1 Product Line Strategy
Novartis Pharmaceutical Corporation
 2 Technology Innovation
Isotechnika Inc.
 3 Market Penetration
Roche Laboratories
 4 Product Innovation
SangStat Medical Corporation
 5 Competitive Strategy Award- Abbott Laboratories

3 Solid Organ Transplant Demand and Supply Analysis
A. Total Demand and Supply Analysis
1 Overview
B. Demand and Supply Analysis by Organ Type
1 Kidney Transplants
2 Liver Transplants
3 Heart Transplants
4 Lung Transplants
5 Pancreatic Transplants
6 Intestinal Transplants
7 Combined Organ Transplants

 4 U.S. Chronic Immunosuppressant Therapies Market
 A. Overview
 1 Introduction
 2 Market and Technology Trends
 3 Market Engineering Analysis
 B. Forecasts and Trends
 1 Revenue Forecasts
 2 Revenue Forecast Assumptions
 3 Market Share Analysis
 4 Demand Analysis
 5 Pricing Trends
 C. Competitive Analysis
 1 Product Analysis
Calcineurin Inhibitors
 2 Product Analysis
TOR Inhibitors
 3 Product Analysis
 4 Product Analysis
 5 Competitive Structure
 D. Emerging Technologies
 1 Biotechnology Trends
 2 Product Pipeline

5 U.S. Acute Immunosuppressant Therapies Market
A. Overview
1 Introduction
2 Market and Technology Trends
3 Market Engineering Analysis
B. Forecasts and Trends
             1 Revenue Forecasts and Assumptions
             2 Market Share Analysis
             3 Demand Analysis
             4 Pricing Trends
             C. Competitive Analysis
             1 Product Analysis
            Prophylactic Agents
             2 Product Analysis
            Acute Rejection Episode Treatment Agents
             3 Comparative Studies
             4 Competitive Structure
             5 Product Pipeline

Ordering:   Order Online -

            Order by Fax - using the form below

            Order by Post - print the order form below and sent to

                         Research and Markets,
                         Guinness Centre,
                         Taylors Lane,
                         Dublin 8,
                                                           Page 1 of 2

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-
1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit

Order Information
Please verify that the product information is correct and select the format(s) you require.

               Product Name:           U.S. Organ Transplant Pharmaceuticals Markets
               Web Address:  
               Office Code:            OC8HKPJPQUSTS

Product Formats
Please select the product formats and quantity you require:


               Electronic:               EURO €2,905.00

               Electronic:               EURO €4,008.00

               Electronic and
                                         EURO €4,376.00 + Euro €50.00 Shipping/Handling *
               Hard Copy:
               Electronic and
                                         EURO €3,273.00 + Euro €50.00 Shipping/Handling *
               Hard Copy:

* Shipping/Handling is only charged once per order.

Contact Information
Please enter all the information below in BLOCK CAPITALS

      Title:                  Mr              Mrs           Dr           Miss                 Ms     Prof

      First Name:                                                  Last Name:

      Email Address: *

      Job Title:




      Postal / Zip Code:


      Phone Number:

      Fax Number:

     * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
                                                              Page 1 of 2

Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.

          Pay by credit card:                     American Express

                                                  Diners Club

                                                  Master Card

                                           Cardholder's Name

                                           Cardholder's Signature

                                           Expiry Date

                                           Card Number

                                           CVV Number

                                           Issue Date
                                           (for Diners Club only)

          Pay by check:                    Please post the check, accompanied by this form, to:

                                           Research and Markets,
                                           Guinness Center,
                                           Taylors Lane,
                                           Dublin 8,

                                           Please transfer funds to:
          Pay by wire transfer:
                                           Account number                   833 130 83
                                           Sort code                        98-53-30
                                           Swift code                       ULSBIE2D
                                           IBAN number                      IE78ULSB98533083313083
                                           Bank Address                 Ulster Bank,
                                                                        27-35 Main Street,
                                                                        Co. Dublin,

     If you have a Marketing Code please enter it below:

           Marketing Code:

      Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at

                                              Please fax this form to:
                                  (646) 607-1907 or (646) 964-6609 - From USA
                          +353 1 481 1716 or +353 1 653 1571 - From Rest of World